SEPTEMBER 23, 2005

Company

Alaunos Therapeutics, Inc.

Filed

September 23, 2005

Accession Number

0001013594-05-000412

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →